No Data
Mizuho Securities Maintains Ardent Health Partners(ARDT.US) With Buy Rating
Mizuho Securities Keeps Their Buy Rating on Ardent Health Partners, Inc. (ARDT)
Press Release: Ardent Health Reports Third Quarter 2024 Results
Express News | Ardent Health Raises FY24 Revenue To $5.8B-$5.875B From $5.75B-$5.9B; Updates Diluted EPS To $1.18-$1.32 From $1.23-$1.37
Express News | Ardent Health Partners Q3 2024 GAAP EPS $0.19 Misses $0.30 Estimate, Sales $1.45B Inline
Express News | Ardent Health Partners Inc FY2024 Shr View $1.26, Rev View $5.83 Bln -- LSEG IBES Data
No Data
No Data
